Pubblicazioni ufficiali Valneva

Azioni

Mercato chiuso - Euronext Paris Altri mercati azionari 17:39:17 03/05/2024			Variaz. 5gg	Var. 1 gen.
3,434 ^EUR	+1,60%		-0,29%	-27,25%

26/03	Valneva avvia una sperimentazione di fase iniziale per il candidato vaccino Zika	MT
26/03	Valneva SE avvia la sperimentazione di Fase 1 del candidato vaccino Zika di seconda generazione	CI

Corporate officers' Statement : Sale	21/11/22	CO
Changes in management and corporate officers	17/11/22	CO
Corporate officers' Statement : Sale	16/11/22	CO
Corporate officers' Statement : Sale	16/11/22	CO
Corporate officers' Statement : Sale	16/11/22	CO
3rd quarter results	10/11/22	CO
3rd quarter results	10/11/22	CO
3rd quarter results	10/11/22	CO
Monthly statement on voting rights	31/10/22	CO
Threshold crossings	11/10/22	CO
Threshold crossings	06/10/22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	30/09/22	CO
Transaction note	23/09/22	CO
Monthly statement on voting rights	31/08/22	CO
Monthly statement on voting rights	31/08/22	CO
Slide show half-year results	11/08/22	CO
Half-year report	11/08/22	CO
Half-year report	11/08/22	CO
1st-half-year results	11/08/22	CO
1st-half-year results	11/08/22	CO
Monthly statement on voting rights	31/07/22	CO
Monthly statement on voting rights	31/07/22	CO
Monthly statement on voting rights	30/06/22	CO
Monthly statement on voting rights	30/06/22	CO
Threshold crossings	28/06/22	CO